U-BX Technology Ltd. Announces Pricing of $10Million Initial Public Offering
The Offering is being conducted on a firm commitment basis. The Company has granted
The Offering is expected to close on or about
EF Hutton is acting as the sole bookrunner for the Offering.
The Company intends to use the proceeds from this Offering for 1) research and development (60%); 2) advertising and marketing (30%); and 3) general working capital (10%).
The registration statement on Form F-1 (File No. 333-262412) relating to the Offering, as amended, was filed with the
Before you invest, you should read the prospectus and other documents the Company has filed or will file with the
About
Headquartered in
Forward-Looking Statement
This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, the Company's statements regarding the expected trading of its Ordinary Shares on the Nasdaq Capital Market and the closing of the Offering. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the
For more information, please contact:
Underwriter
Ms.
Email: [email protected]
Investor Relations
WFS Investor Relations Inc.
Email: [email protected]
Phone: +86 13811768599
+1 628 283 9214
Source:
Medicaid eligibility during pandemic led to increased postpartum coverage, study suggests: Michigan Medicine – University of Michigan
Hamilton to Report First Quarter 2024 Financial Results on May 8, 2024
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News